Laura V. Hale

872 total citations
17 papers, 741 citations indexed

About

Laura V. Hale is a scholar working on Molecular Biology, Oncology and Rheumatology. According to data from OpenAlex, Laura V. Hale has authored 17 papers receiving a total of 741 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Oncology and 4 papers in Rheumatology. Recurrent topics in Laura V. Hale's work include Bone health and treatments (6 papers), Bone Metabolism and Diseases (4 papers) and Cell Adhesion Molecules Research (3 papers). Laura V. Hale is often cited by papers focused on Bone health and treatments (6 papers), Bone Metabolism and Diseases (4 papers) and Cell Adhesion Molecules Research (3 papers). Laura V. Hale collaborates with scholars based in United States and Finland. Laura V. Hale's co-authors include Robert F. Santerre, Rebecca R. Miles, John E. Hale, George Boguslawski, Yoshinori Ishikawa, J.E. Onyia, Rachelle J. Sells Galvin, Roy E. Wuthier, Thomas C. Register and Jia En Chin and has published in prestigious journals such as Journal of Biological Chemistry, Endocrinology and Methods in enzymology on CD-ROM/Methods in enzymology.

In The Last Decade

Laura V. Hale

17 papers receiving 724 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura V. Hale United States 12 362 182 171 97 92 17 741
Cyril Thouverey Switzerland 17 510 1.4× 182 1.0× 190 1.1× 180 1.9× 92 1.0× 24 900
Steven L. Smock United States 15 608 1.7× 249 1.4× 120 0.7× 108 1.1× 256 2.8× 17 1.1k
Ada Staal Netherlands 13 455 1.3× 170 0.9× 62 0.4× 55 0.6× 129 1.4× 16 725
Hyon J. Kim United States 15 463 1.3× 103 0.6× 99 0.6× 71 0.7× 145 1.6× 33 824
Licia N.Y. Wu United States 21 456 1.3× 133 0.7× 298 1.7× 321 3.3× 105 1.1× 43 1.0k
Carmen Huesa United Kingdom 17 322 0.9× 99 0.5× 357 2.1× 252 2.6× 151 1.6× 42 896
Emel Esen United States 9 662 1.8× 206 1.1× 72 0.4× 55 0.6× 115 1.3× 10 965
Ramesh Rajpurohit United States 11 507 1.4× 58 0.3× 232 1.4× 46 0.5× 50 0.5× 19 905
Motoyuki Uchida Japan 13 297 0.8× 111 0.6× 61 0.4× 49 0.5× 156 1.7× 18 658
Amy Y. Sato United States 13 560 1.5× 312 1.7× 92 0.5× 92 0.9× 112 1.2× 21 918

Countries citing papers authored by Laura V. Hale

Since Specialization
Citations

This map shows the geographic impact of Laura V. Hale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura V. Hale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura V. Hale more than expected).

Fields of papers citing papers by Laura V. Hale

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura V. Hale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura V. Hale. The network helps show where Laura V. Hale may publish in the future.

Co-authorship network of co-authors of Laura V. Hale

This figure shows the co-authorship network connecting the top 25 collaborators of Laura V. Hale. A scholar is included among the top collaborators of Laura V. Hale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura V. Hale. Laura V. Hale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
2.
Han, Bomie, Andrew G. Geiser, Laura V. Hale, et al.. (2007). Development of a Highly Sensitive, High-Throughput, Mass Spectrometry-Based Assay for Rat Procollagen Type-I N-Terminal Propeptide (PINP) To Measure Bone Formation Activity. Journal of Proteome Research. 6(11). 4218–4229. 22 indexed citations
3.
Hale, Laura V., Rachelle J. Sells Galvin, Juha Risteli, et al.. (2006). PINP: A serum biomarker of bone formation in the rat. Bone. 40(4). 1103–1109. 64 indexed citations
4.
Galvin, Rachelle J. Sells, et al.. (2006). Screening for Activators of the Wingless Type/Frizzled Pathway by Automated Fluorescent Microscopy. Methods in enzymology on CD-ROM/Methods in enzymology. 414. 140–150. 6 indexed citations
5.
Galvin, Rachelle J. Sells, Charles A. Frolik, Laura V. Hale, et al.. (2005). High-Content Screening Assay for Activators of the Wnt/Fzd Pathway in Primary Human Cells. Assay and Drug Development Technologies. 3(2). 133–141. 35 indexed citations
6.
Miles, Rebecca R., James P. Sluka, David L. Halladay, et al.. (2002). Parathyroid hormone (hPTH 1–38) stimulates the expression of UBP41, an ubiquitin‐specific protease, in bone. Journal of Cellular Biochemistry. 85(2). 229–242. 17 indexed citations
7.
Boguslawski, George, Laura V. Hale, Xiaopeng Yu, et al.. (2000). Activation of Osteocalcin Transcription Involves Interaction of Protein Kinase A- and Protein Kinase C-dependent Pathways. Journal of Biological Chemistry. 275(2). 999–1006. 82 indexed citations
8.
Miles, Rebecca R., James P. Sluka, Robert F. Santerre, et al.. (2000). Dynamic Regulation of RGS2 in Bone: Potential New Insights into Parathyroid Hormone Signaling Mechanisms. Endocrinology. 141(1). 28–36. 54 indexed citations
9.
Hale, Laura V., et al.. (2000). Semi-Quantitative Fluorescence Analysis of Calcein Binding as a Measurement of In Vitro Mineralization. Calcified Tissue International. 67(1). 80–84. 75 indexed citations
10.
Miles, Rebecca R., James P. Sluka, David L. Halladay, et al.. (2000). ADAMTS-1: A Cellular Disintegrin and Metalloprotease with Thrombospondin Motifs Is a Target for Parathyroid Hormone in Bone. Endocrinology. 141(12). 4533–4542. 51 indexed citations
11.
Onyia, J.E., Laura V. Hale, Rebecca R. Miles, et al.. (1999). Molecular Characterization of Gene Expression Changes in ROS 17/2.8 Cells Cultured in Diffusion Chambers In Vivo. Calcified Tissue International. 65(2). 133–138. 10 indexed citations
12.
Hale, Laura V., et al.. (1997). Rapid tumor development with a modified MCF-7 xenograft model.. PubMed. 47(1). 82–5. 3 indexed citations
13.
Fuchs‐Young, Robin, S R Howe, Laura V. Hale, Rebecca R. Miles, & Cheryl L. Walker. (1996). Inhibition of estrogen-stimulated growth of uterine leiomyomas by selective estrogen receptor modulators. Molecular Carcinogenesis. 17(3). 151–159. 61 indexed citations
14.
Hale, Laura V.. (1996). Raloxifene, a selective estrogen receptor modulator, inhibits estrogen stimulated proliferation of leiomyoma cells in culture.. Journal of the Society for Gynecologic Investigation. 3(2). 335A–335A. 2 indexed citations
15.
Hale, Laura V., et al.. (1986). Effect of vitamin D metabolites on the expression of alkaline phosphatase activity by epiphyseal hypertrophic chondrocytes in primary cell culture. Journal of Bone and Mineral Research. 1(6). 489–495. 94 indexed citations
16.
Hale, Laura V., et al.. (1986). Development of a new serum-free medium, USC-HC1, for growth and normal phenotype in postembryonic chicken growth plate chondrocytes. In Vitro Cellular & Developmental Biology - Plant. 22(10). 597–603. 7 indexed citations
17.
Wuthier, Roy E., Jia En Chin, John E. Hale, et al.. (1985). Isolation and characterization of calcium-accumulating matrix vesicles from chondrocytes of chicken epiphyseal growth plate cartilage in primary culture.. Journal of Biological Chemistry. 260(29). 15972–15979. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026